• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Harmony Biosciences Holdings, Inc. - Common Stock (NQ:HRMY)

34.45 +0.29 (+0.85%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 864,267
Open 34.50
Bid (Size) 34.25 (100)
Ask (Size) 36.26 (300)
Prev. Close 34.16
Today's Range 34.33 - 35.12
52wk Range 25.52 - 40.87
Shares Outstanding 57,031,297
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Harmony Biosciences Announces Poster Presentations at 2026 SLEEP Annual Meeting
June 11, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
Harmony (HRMY) Q1 2026 Earnings Transcript ↗
June 01, 2026
Harmony (HRMY) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Intellectual Property

Performance

YTD
-7.8%
-7.8%
1 Month
+14.5%
+14.5%
3 Month
+24.9%
+24.9%
6 Month
-10.5%
-10.5%
1 Year
+7.5%
+7.5%

More News

Read More
News headline image
Harmony Biosciences to Participate in Upcoming Investor Conferences
May 27, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
A Healthcare Fund Just Made Bitgo Its Biggest Bet ↗
May 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
Harmony Biosciences Holdings (NASDAQ:HRMY) Q1 Revenue Meets Guidance, But EPS Miss and Elevated Spending Weigh on Shares ↗
May 07, 2026
Via Chartmill
Harmony Biosciences Holdings (NASDAQ:HRMY): A Decent Value Play with Strong Fundamentals ↗
April 28, 2026
Via Chartmill
News headline image
A beaten-down biotech just lost a meaningful backer — should you care? ↗
May 19, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities
May 07, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
Harmony Biosciences to Report First Quarter 2026 Financial Results on May 7, 2026
April 23, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
Harmony Biosciences to Present Open-Label Extension Data From Phase 3 ARGUS Trial at the 2026 American Academy of Neurology Annual Meeting
April 16, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Case for Quality at a Discount ↗
March 13, 2026
Via Chartmill
Harmony Biosciences Holdings (NASDAQ:HRMY) Reports Q4 2025 Revenue In Line, Earnings Miss Amid Pipeline Investment ↗
February 24, 2026
Via Chartmill
Topics Earnings
News headline image
Harmony Biosciences Appoints Glenn Reicin as Chief Financial Officer
April 14, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
Soleno Therapeutics: A Masterclass in Rare Disease Redemption and the $2.9B Exit
April 07, 2026
Via Finterra
Topics Economy Intellectual Property
News headline image
Lilly’s $7.8 Billion Centessa Bet: Inside the Race to Dominate the Sleep Market’s ‘Orexin Gold Rush’
April 06, 2026
Via MarketMinute
Harmony Biosciences Holdings (NASDAQ:HRMY) Emerges as a Compelling Value and Growth Pick ↗
February 20, 2026
Via Chartmill
Harmony Biosciences Holdings (NASDAQ:HRMY) Presents a Compelling Mix of Strong Fundamentals and Bullish Technical Setup ↗
February 17, 2026
Via Chartmill
News headline image
Neurocrine Biosciences to Acquire Soleno Therapeutics in $2.9 Billion Deal as VYKAT™ XR Sales Soar
April 06, 2026
Via MarketMinute
Topics Intellectual Property
News headline image
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board
April 02, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
Harmony Biosciences to Participate in 25th Annual Needham Virtual Healthcare Conference
March 31, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
Harmony Biosciences to Participate in Upcoming Investor Conferences
March 04, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
Harmony Biosciences (HRMY) Earnings Transcript ↗
February 24, 2026
Via The Motley Fool
News headline image
Harmony Biosciences Reports Strong 2025 Financial Results and Reiterates 2026 Net Revenue Guidance of Over $1 Billion
February 24, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire
News headline image
HRMY Stock Rises On Fresh FDA Approval For Wakix Tablets In Children But Wall Street Eyes Further Rally ↗
February 17, 2026
Via Stocktwits
News headline image
Harmony Biosciences Receives U.S. Food and Drug Administration Approval for WAKIX® (pitolisant) for the Treatment of Cataplexy in Pediatric Narcolepsy
February 17, 2026
From Harmony Biosciences Holdings, Inc.
Via Business Wire

Frequently Asked Questions

Is Harmony Biosciences Holdings, Inc. - Common Stock publicly traded?
Yes, Harmony Biosciences Holdings, Inc. - Common Stock is publicly traded.
What exchange does Harmony Biosciences Holdings, Inc. - Common Stock trade on?
Harmony Biosciences Holdings, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock?
The ticker symbol for Harmony Biosciences Holdings, Inc. - Common Stock is HRMY on the Nasdaq Stock Market
What is the current price of Harmony Biosciences Holdings, Inc. - Common Stock?
The current price of Harmony Biosciences Holdings, Inc. - Common Stock is 34.45
When was Harmony Biosciences Holdings, Inc. - Common Stock last traded?
The last trade of Harmony Biosciences Holdings, Inc. - Common Stock was at 06/24/26 04:00 PM ET
What is the market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock?
The market capitalization of Harmony Biosciences Holdings, Inc. - Common Stock is 1.96B
How many shares of Harmony Biosciences Holdings, Inc. - Common Stock are outstanding?
Harmony Biosciences Holdings, Inc. - Common Stock has 2B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap